Clinical safety and efficacy of everolimus-eluting stents compared to paclitaxel-eluting stents in patients with coronary artery disease

Author： Zhang Feng   Dong Lili   Qian Juying   Ge Junbo  

Publisher： Informa Healthcare

ISSN： 0785-3890

Source： Annals of Medicine, Vol.43, Iss.1, 2011-02, pp. : 75-79

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long‐term safety and efficacy of second‐generation everolimus‐eluting stents compared to other limus‐eluting stents and bare metal stents in patients with acute coronary syndrome

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 84, Iss. 7, 2014-12 ,pp. : 1053-1060

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparisons of Everolimus and Paclitaxel‐Eluting Stents in Patients with Acute Myocardial Infarction

By  

JOURNAL OF INTERVENTIONAL CARDIOLOGY, Vol. 28, Iss. 2, 2015-04 ,pp. : 147-156

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rationale and Design of a Randomized Clinical Comparison of Everolimus-Eluting (Xience V/Promus) and Sirolimus-Eluting (Cypher Select+) Coronary Stents in Unselected Patients with Coronary Heart Disease

By  

Cardiology, Vol. 116, Iss. 2, 2010-06 ,pp. : 73-78

Karger

Access to resources Recommend Favorite

Clinical efficacy of drug-eluting stents in patients with diabetes

By Dieter Robert S   Ahmed Mohammed   Ikram Sohail   Pacanowski Jr John P   Nanjundappa Aravinda  

Therapy, Vol. 3, Iss. 1, 2006-01 ,pp. : 1-3

Future Medicine

Access to resources Recommend Favorite

A 10‐month angiographic and 4‐year clinical outcome of everolimus‐eluting versus sirolimus‐eluting coronary stents in patients with diabetes mellitus (the diabedES IV randomized angiography trial)

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 86, Iss. 7, 2015-12 ,pp. : 1161-1167

John Wiley & Sons Inc

Access to resources Recommend Favorite